` Comparison: ALK B, NOVO B - Alpha Spread

ALK B
vs
NOVO B

Over the past 12 months, ALK B has significantly outperformed NOVO B, delivering a return of +26% compared to the NOVO B's 55% drop.

Smart Verdict
AI-Powered

Not Sure Which Stock Wins?
Let AI Decide.
ALK B
NOVO B
One-click summary across all key metrics.
Ranked results with clear takeaways.
No spreadsheets, no guesswork.
One-click summary across all key metrics.
Ranked results with clear takeaways.
No spreadsheets, no guesswork.
Start AI Comparison
Valuation
Growth
Profitability
Solvency
Comparing Valuation
Running a multi-layered valuation analysis to compare how attractive each stock is.
Comparing Growth
Financial growth, forecasts, volatility, and historical drawdowns.
Comparing Profitability
Margins, returns on capital, and the consistency of profitability.
Comparing Solvency
Debt levels, liquidity, interest coverage, and bankruptcy risk.
Summarizing...
We need a little more time to summarize the results

Valuation Comparison

ALK B Intrinsic Value
186.4 DKK
Overvaluation 2%
Intrinsic Value
Price
NOVO B Intrinsic Value
645.4 DKK
Undervaluation 36%
Intrinsic Value
Price
Company Last Price Intrinsic Value DCF Value Relative Value Wall St Target
ALK-Abello A/S
CSE:ALK B
190.3 DKK
Novo Nordisk A/S
CSE:NOVO B
411 DKK
Valuation Scenario:
Bear Case
Base Case
Bull Case

Growth Comparison

Growth Over Time
ALK B, NOVO B

ALK B
NOVO B
Add Stock
Revenue
www.alphaspread.com
Company LTM Historical Growth Growth Streak % Positive Years Max Drawdown Volatility Forecasted Growth
3 Years 5 Years 10 Years 1 Year 3 Years
ALK-Abello A/S
Revenue
Novo Nordisk A/S
Revenue

All metrics are calculated based on data from the last 10 years.

Profitability Comparison

Free Cash Flow
ALK B, NOVO B

ALK B
NOVO B
Add Stock
Free Cash Flow
www.alphaspread.com
Company LTM Average Historical Growth FCF Margin Conversion
3 Years 5 Years 3 Years 5 Years 10 Years
ALK-Abello A/S
CSE:ALK B
Novo Nordisk A/S
CSE:NOVO B
What is Free Cash Flow?

Gross Margin

ALK B
64.5%
NOVO B
84.3%
LTM 3Y Avg 5Y Avg 10Y Avg
ALK-Abello A/S
Novo Nordisk A/S

Operating Margin

ALK B
21.8%
NOVO B
44.6%
LTM 3Y Avg 5Y Avg 10Y Avg
ALK-Abello A/S
Novo Nordisk A/S

Net Margin

ALK B
16.4%
NOVO B
34.5%
LTM 3Y Avg 5Y Avg 10Y Avg
ALK-Abello A/S
Novo Nordisk A/S

FCF Margin

ALK B
0.3%
NOVO B
24.5%
LTM 3Y Avg 5Y Avg 10Y Avg
ALK-Abello A/S
Novo Nordisk A/S

ROE

ALK B
18.1%
NOVO B
88.1%
LTM 3Y Avg 5Y Avg 10Y Avg
ALK-Abello A/S
Novo Nordisk A/S

ROA

ALK B
12.5%
NOVO B
26.6%
LTM 3Y Avg 5Y Avg 10Y Avg
ALK-Abello A/S
Novo Nordisk A/S

ROIC

ALK B
13.7%
NOVO B
30.4%
LTM 3Y Avg 5Y Avg 10Y Avg
ALK-Abello A/S
Novo Nordisk A/S

ROCE

ALK B
20.3%
NOVO B
70%
LTM 3Y Avg 5Y Avg 10Y Avg
ALK-Abello A/S
Novo Nordisk A/S

Solvency Comparison

Balance Sheet Comparison

Stocks Performance

Stocks Performance
ALK B, NOVO B

Loading
ALK B
NOVO B
Add Stock
www.alphaspread.com

Performance Gap
ALK B, NOVO B

Loading
ALK B
NOVO B
Difference
www.alphaspread.com

Performance By Year
ALK B, NOVO B

Loading
ALK B
NOVO B
Add Stock
Not Sure Which Stock Wins?
Let AI Decide
One-click summary across all key metrics.
Ranked results with clear takeaways.
No spreadsheets, no guesswork.
Start AI Comparison
Compare ALK B to other stocks
Unlock Full Access to Alpha Spread
Create Free Account